Imaging EGFR and HER3 through (89)Zr-labeled MEHD7945A (Duligotuzumab)

Tumor resistance to treatment paved the way toward the development of single agent drugs that target multiple molecular signatures amplified within the malignancy. The discovered crosstalk between EGFR and HER3 as well as the role of HER3 in mediating EGFR resistance made these two receptor tyrosine...

Descripción completa

Detalles Bibliográficos
Autores principales: McKnight, Brooke N., Kuda-Wedagedara, Akhila N. W., Sevak, Kuntal K., Abdel-Atti, Dalya, Wiesend, Wendy N., Ku, Anson, Selvakumar, Dakshnamurthy, Carlin, Sean D., Lewis, Jason S., Viola-Villegas, Nerissa T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5998059/
https://www.ncbi.nlm.nih.gov/pubmed/29899472
http://dx.doi.org/10.1038/s41598-018-27454-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5998059/
https://www.ncbi.nlm.nih.gov/pubmed/29899472
http://dx.doi.org/10.1038/s41598-018-27454-6

Ejemplares similares